Serum CTRP9 Reflects Coronary Collateralization in Nondiabetic Patients with Obstructive Coronary Artery Disease

Table 2

Multivariate logistic regression analysis for the discrimination of impaired collateralization in the diabetic group.

Variables	Univariate		Multivariate
	OR (95% CI)	value	OR (95% CI)	value
UAP	1.42 (0.31-6.47)	0.653	0.58 (0.05-7.06)	0.671
HR	1.08 (0.97-1.20)	0.155	1.18 (0.95-1.46)	0.134
Hyperlipidemia	0.61 (0.06-6.55)	0.680	0.21 (0.01-55.82)	0.206
MetS	0.33 (0.03-3.18)	0.336	0.90 (0.02-47.66)	0.895
eGFR	1.00 (0.94-1.06)	0.908	0.95 (0.86-1.06)	0.355
HDL-C	0.64 (0.02-26.97)	0.816	0.07 (0.01-136.32)	0.483
Log hs-CRP	0.55 (0.10-3.02)	0.488	0.31 (0.02-4.84)	0.404
SYNTAX score	1.01 (0.93-1.11)	0.758	1.04 (0.90-1.19)	0.623
Diseased artery in LAD	0.39 (0.09-1.77)	0.222	0.07 (0.01-2.30)	0.136
Diseased artery in RCA	1.56 (0.38-6.36)	0.538	0.14 (0.01-3.60)	0.237
CTRP9 (T2)	1.67 (0.29-9.45)	0.564	1.24 (0.10-15.01)	0.865
CTRP9 (T3)	1.09 (0.21-5.76)	0.916	1.05 (0.07-16.50)	0.975

Abbreviations: UAP: unstable angina pectoris; HR: heart rate; MetS: metabolic syndrome; eGFR: estimated glomerular filtration rate; HDL-C: high-density lipoprotein cholesterol; Hs-CRP: high-sensitivity C-reactive protein; LAD: left anterior descending artery; RCA: right coronary artery; CTRP9: C1q/tumor necrosis factor-related protein 9.